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Objectives: Pneumococcal nasopharyngeal carriage occurs early in life. However, the role of vertical
transmission is not well understood. The aims of this study were to describe carriage among mothers and
their newborns, and to assess for risk factors for neonatal carriage.
Methods: In a nested retrospective cohort study, we analysed data from the control arm of a randomized
controlled trial conducted in The Gambia 2 to 3 years after introduction of pneumococcal conjugate
vaccine (PCV) 13. Nasopharyngeal swabs were collected from 374 women and their newborns on the day
of delivery, then 3, 6, 14 and 28 days later. Pneumococci were isolated and serotyped using conventional
microbiologic methods.
Results: Carriage increased from 0.3% (1/373) at birth to 37.2% (139/374) at day 28 (p <0.001) among
neonates and from 17.1% (64/374) to 24.3% (91/374) (p 0.015) among women. In both groups, PCV13
vaccine-type (VT) serotypes accounted for approximately one-third of the pneumococcal isolates, with
serotype 19A being the most common VT. Maternal carriage (adjusted odds ratio (OR) ¼ 2.82; 95%
conﬁdence interval (CI), 1.77e4.80), living with other children in the household (adjusted OR ¼ 4.06; 95%
CI, 1.90e8.86) and dry season (OR ¼ 1.98; 95% CI, 1.15e3.43) were risk factors for neonatal carriage. Over
half (62.6%) of the neonatal carriage was attributable to living with other children in the same household.
Conclusions: Three years after the introduction of PCV in The Gambia, newborns are still rapidly colo-
nized with pneumococcus, including PCV13 VT. Current strategies for pneumococcal control in Africa do
not protect this age group beyond the herd effect. E. Usuf, Clin Microbiol Infect 2017;▪:1
© 2017 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and
Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Streptococcus pneumoniae is a leading cause of morbidity and
mortality in children under 2 years of age [1,2]. Generally, invasive
pneumococcal disease (IPD) peaks in the second year of life in
developed countries and in the ﬁrst year of life in sub-Saharan
Africa [3,4]. Nevertheless, a substantial burden of neonatal IPD
has been reported across different regions worldwide, althoughCouncil Unit, PO Box 273,
Ltd on behalf of European Society
g/licenses/by-nc-nd/4.0/).
l., Maternal pneumococcal na
accines in The Gambia, Clidata are lacking in the least developed countries [5e10]. In a recent
systematic review, the global pooled neonatal IPD was estimated at
36 per 100 000 live births (95% conﬁdence interval (CI), 20.0e64.7)
[5]. From one study in The Gambia, it was estimated as 369.5 per
100 000 (95% CI, 119.2e1138.5) [3,5].
Pneumococcal conjugate vaccines (PCVs) are effective against
IPD and nasopharyngeal carriage of vaccine serotypes (VT). The
latter is important because carriage is a preliminary step towards
disease and a measure of community transmission. The introduc-
tion of PCV has been shown to reduce acquisition of VT nasopha-
ryngeal carriage among both vaccinated [11] and unvaccinated
individuals [12]. However, it has also been shown to increase non-of Clinical Microbiology and Infectious Diseases. This is an open access article under
sopharyngeal carriage and risk factors for neonatal carriage after the
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mains similar [11].
Since 2009, three formulations of PCV targeting pneumococcal
serotypes most commonly associated with IPD worldwide have
been introduced into routine vaccination in sub-Saharan Africa,
ﬁrst PCV7, then PCV10 and PCV13. Although two randomized trials
in Kenya and Papua New Guinea showed that PCVs are immuno-
genic and well tolerated when given at birth [13,14], the World
Health Organization (WHO) recommends vaccination with PCVs
from 6weeks of age [15]. This means newborns until 6 weeks of age
are only protected through indirect effects (i.e. maternal antibodies
and herd effect) [16e18]. New strategies are required to reduce
early infection and tominimize its long-term effects such as growth
impairment and neurologic sequelae [19e21].
Risk factors for pneumococcal nasopharyngeal carriage are well
known for African children [22e25] but not for newborns. In this
study, we assessed the prevalence of pneumococcal carriage among
women and their newborns in The Gambia and analyzed risk fac-
tors for neonatal carriage after the implementation of PCV through
an expanded program on immunization.
Materials and Methods
Study site
The study was conducted at the Jammeh Foundation for Peace, a
public health facility in Western Gambia. PCV7 was introduced in
The Gambia in August 2009 and was replaced by PCV13 in May
2011. Coverage of two or more doses of PCV13 before 12 months of
age was 94% among rural Gambian children born in the second half
of 2013 [26].
Study design
This was a retrospective nested cohort study. The study cohort
comprised motherenewborn pairs included in the placebo arm of a
phase 3, double-blind, placebo-controlled, randomized trial in
which women in labour were randomized to receive a single dose
of 2 g of oral azithromycin or placebo (292.7 mg pregelatinized
starch, 881.8 mg dibasic calcium phosphate and 11.5 mg magne-
sium stearate coated with 18 mg Opadry). Study women aged 18 to
45 years were recruited between April 2013 and April 2014 when
attending prenatal clinic.
Nasopharyngeal swabs (NPS) were collected from mothers and
their newborns during the 28 days of active follow-up. An NPS was
collected fromwomen in labour and from newborns within 6 hours
of birth. Additional maternal and newborn NPS were collected at
days 3, 6, 14 and 28 during household visits conducted by study
nurses and ﬁeld workers. Sample collection was discontinued if
participants received antibiotics as part of standard care.
Epidemiologic data including demographic and other risk factor
data were collected by trained ﬁeld staff using questionnaires.
Sample collection
All NPS were collected in accordance with theWHO protocol for
detecting S. pneumoniae in the upper respiratory tract [27] and as
described previously [28].
Bacterial Isolation
Stored NPS were plated on appropriate agar for selective isola-
tion of S. pneumoniae and Staphylococcus aureus [28]. All pneu-
mococcal isolates were serotyped by using the latex agglutination
test (Statens Serum Institute, Copenhagen, Denmark) [29].Please cite this article in press as: Usuf E, et al., Maternal pneumococcal n
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All data were double entered into Openclinica and analysed by
Stata 14 (StataCorp, College Station, TX, USA). The analysis was
restricted to mothers and newborns in the placebo arm of the trial
that were not missing day 28 carriage data.
The prevalence of PCV13 VT carriage (i.e. carriage of serotypes 1,
3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F or 23F) and non-vaccine-
type carriage was calculated for 0, 3, 6 and 14 days after birth
where the latter included nontypeable isolates. We estimated the
proportion of concordant pairs, deﬁned as the proportion of
motherenewborn carrier pairs where both mother and newborn
carried the same serotype, either concurrently or at different
times, during the neonatal period. The association between
maternal carriageddeﬁned as carriage at any time during the
neonatal perioddand neonatal carriage at day 28 was investigated
by logistic regression. The following potential confounders were
selected a priori for inclusion in the model [30]: birth weight, other
children in the household, mother's age, mother's education and
season.
The association between other children living in the household
and neonatal carriage at day 28 was also investigated. The potential
confounders listed above were included in this second model,
except for ‘other children in the household,’ because this variable
was already included as the exposure of interest. The model did not
include maternal carriage because this may be on the causal
pathway.
A similar analysis was conducted for the association between
maternal carriage at day 14 and acquisition of carriage in the
newborn between day 6 and day 14di.e. carriage of any serotype at
day 14 among noncarriers at day 6, and for the association between
neonatal carriage at day 14 and acquisition of carriage in the
mother over the same period.
The percentage of neonatal carriage attributable to each risk
factordi.e. maternal carriage and living with other children, the
population-attributable fractiondwas calculated using the ‘punaf’
command in Stata [31].
Ethical approval
The trial was approved by the joint Medical Research Council
GroupeGambia Government Ethics Committee (ClinicalTrials.gov
NCT01800942).
Results
Characteristics of mothers and newborns
There were 417 motherenewborn pairs in the placebo arm of
the trial, and 374 (89.7%) were included in the analysis. As there
were four sets of twins, only 370 women were sampled. The me-
dian age of the mothers was 26 years (interquartile range,
22e30 years). Approximately half of the women had less than
1 year of any schooling (184/359, 51.2%). Forty-seven percent (173/
367) of newborns were girls. The median birth weight was 3.1 kg
(interquartile range, 2.9e3.4 kg), and 22 (5.9%) of 373 were low
birth weight (<2.5 kg). All the newborns were breastfed; only seven
were not exclusively breastfed.
Maternal and newborn pneumococcal nasopharyngeal carriage
Among the mothers, carriage increased from 17.1% to 24.3% (p
0.015) between days 0 and 28, and among newborns it increased
from 0.3% to 37.2% (p <0.001) (Fig. 1). PCV13 VT represented
approximately one-third (28.2%) of all pneumococci isolates, 27.1%asopharyngeal carriage and risk factors for neonatal carriage after the
nical Microbiology and Infection (2017), http://dx.doi.org/10.1016/
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Fig. 1. Pneumococcal nasopharyngeal carriage in mothers and newborns. VT, vaccine type; NVT, nonevaccine type.
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Serotype 19A was the most common serotype among newborns
and the second most common among mothers. Nontypeable
pneumococci were also common among both mothers (36/366,
9.8%) and newborns (14/234, 6.0%). Only ﬁve mothers and seven
newborns carried multiple serotypes during the study period.0
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carrier but the newborn was not, and in 56 pairs (15.0%) the
newbornwas a carrier but the mother was not. Among the 97 pairs
(25.9%) where both the mother and newborn were carriers, 47
(48.5%; 95% CI, 38.2e58.9) were concordant (i.e. carried the same
serotype). Of these, 31.9% (15/47) pairs were concordant with VT;40 35 9A 12
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Fig. 3. Frequency of concordant serotypes among motherenewborn pairs. Red bars,
vaccine type serotypes; blue bars, nonevaccine type.
Table 1
Risk factors for neonatal nasopharyngeal pneumococcal carriage at day 28 (N ¼ 374)
Characteristic Variable Carriage, n (%)
Newborn
Gender Female 67 (38.7)
Male 72 (37.1)
Birth weight <2.5 kg 3 (13.6)
2.5 kg 136 (38.8)
Gestational age <37 weeks 85 (38.8)
37 weeks 54 (35.5)
Staphylococcus aureus carriage at day 28 No 87 (36.0)
Yes 52 (39.4)
Maternal
Mother carrier Streptococcus
pneumoniae at day 28
No 94 (33.2)
Yes 45 (49.5)
Mother carrier day 14 and carrier day 28 No 117 (35.1)
Yes 22 (53.7)
Mother carrier day 28, noncarrier day 14 No 118 (36.2)
Yes 21 (43.8)
Mother carrier any time during
neonatal period
No 54 (26.9)
Yes 85 (49.1)
Mother S. aureus carrier at day 28 No 99 (36.0)
Yes 40 (40.4)
Mother's age <25 years 72 (34.0)
25 years 67 (41.6)
Ethnicity Mandinka 54 (32.7)
Wollof 17 (40.5)
Jola 22 (42.3)
Fula 25 (44.6)
Others 21 (35.6)
Mother's years of schooling None or <1 year 74 (40.2)
1 year 59 (33.7)
Mother can read No 99 (40.4)
Yes 40 (31.0)
Mother can write No 98 (40.2)
Yes 41 (31.5)
Household
Smoker in house No 126 (36.7)
Yes 13 (41.9)
Who bathes child Mother 82 (40.4)
Other 53 (32.9)
Other children in household No 10 (13.9)
Yes 129 (42.7)
Number of children at school 0 62 (34.3)
1 76 (39.8)
Other factors
Season Rainy 30 (27.5)
Dry 109 (41.1)
CI, conﬁdence interval; OR, odds ratio.
Adjusted OR adjusted for birth weight, other children living in household, mother's age,
a Model did not include maternal carriage, thought to be on the causal pathway.
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j.cmi.2017.07.01819F was the most common, at 8.5% (4/47). There were four
concordant cases among those who did not have other children in
the household (serotypes 9N, 19F, 21 and 47) (Fig. 3).
Risk factors for pneumococcal nasopharyngeal carriage in newborns
In the univariable analysis, the prevalence of carriage at day 28
was higher in newborns born during the dry season (odds ratio
(OR) ¼ 1.84; 95% CI, 1.13e2.99), those whose mothers were carriers
(OR ¼ 2.63; 95% CI, 1.71e4.05), those living with other children
(OR ¼ 4.62; 95% CI, 2.28e9.36) and those with normal birth weight
(OR ¼ 4.00; 95% CI, 1.16e13.79) (Table 1).
Maternal carriage remained a risk factor for neonatal carriage
after adjusting for birth weight, other children in household,
mother's age, mother's education and season (adjusted OR ¼ 2.69;
95% CI, 1.68e4.30; p <0.001). Living with other children in the
household after adjusting for birth weight, mother's age, mother's
education and season was also a risk factor for neonatal carriage atTotal (N) Crude Adjusted p
OR (95% CI) p OR
173 1
194 0.93 (0.61e1.42) 0.750
22 1 1
351 4.00 (1.16e13.79) 0.028 3.461 (0.91e13.11) 0.068
219 1
152 0.87 (0.56e1.33) 0.520
242 1
132 1.15 (0.75e1.79) 0.510
283 1
91 1.97 (1.21e3.18) 0.006
333 1
41 2.13 (1.11e4.11) 0.023
326 1
48 1.37 (0.74e2.53) 0.313
201 1 1
173 2.63 (1.71e4.05) <0.001 2.82 (1.77e4.80) <0.001
275 1
99 1.21 (0.75e1.93) 0.437
212 1
161 1.39 (0.91e2.11) 0.131
165 1 0.469
42 1.40 (0.70e2.81)
52 1.51 (0.80e2.86)
56 1.66 (0.89e3.08)
59 1.13 (0.61e2.12)
184 1
175 0.76 (0.49e1.16) 0.203
245 1
129 0.66 (0.42e1.04) 0.075
244 1
130 0.69 (0.44e1.08) 0.101
343 1
31 1.24 (0.59e2.62) 0.567
203 1
161 0.72 (0.47e1.11) 0.143
72 1 1
302 4.62 (2.28e9.36) <0.001 4.06 (1.90e8.86)a <0.001
181 1
191 1.26 (0.83e1.93) 0.270
109 1 1
265 1.84 (1.13e2.99) 0.014 1.98 (1.15e3.43) 0.014
mother's education and season.
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fraction of neonatal carriage at day 28 attributed to maternal
carriage was 10.6% (95% CI, 2.5e18.0), and the fraction attributable
to living with other children in the household was 62.6% (95% CI,
35.4e78.4).
Mothers who were not carriers at day 6 had a higher carriage at
day 14 if their baby was a carrier at day 14, although this was not
statistically signiﬁcant (adjusted OR ¼ 1.54; 95% CI, 0.75e3.18; p
0.326). Newborns who were not carriers at day 6 had a higher risk
of being a carrier at day 14 if their mother was a carrier at day 14
(adjusted OR ¼ 1.88; 95% CI, 1.01e3.48; p 0.045).
Discussion
The prevalence of pneumococcal nasopharyngeal carriage
among Gambian women and their newborns during the 4 weeks
after delivery was high. Although the study was conducted 2 to
3 years after routine PCV13 introduction (and 4 to 5 years after
PCV7 introduction), one-third of the serotypes identiﬁed were
PCV13 VT. Both maternal carriage and living with other children in
the household were risk factors for neonatal carriage, with the
latter accounting for almost two-thirds of neonatal carriage.
The prevalence of neonatal colonization (37.2%) was lower than
in two previous studies conducted before PCV introduction in The
Gambia. In both these studies, the prevalence was more than 50%
by the age of 4 weeks [17,32]. One difference between these pre-
vious studies and ours is that the former were conducted in rural
areas where most deliveries occurred at home, while the latter was
conducted in a periurban health facility.
A striking ﬁnding in our study was the sharp increase in carriage
in both mothers and newborns between days 6 and 14 (carriage in
newborns continued to increase up to day 28). In The Gambia,
newborns are given their name at day 7 after birth in a naming
ceremony, and this is usually preceded by cooking and people
moving around the compound. This may increase pneumococcal
transmission during this period as people visit the mother and
newborn. In line with our results, a previous longitudinal study in
rural Gambia showed that maternal carriage doubled within the
ﬁrst 2 months after delivery and remained high until the end of
1 year, when follow-up ended [33].
In our study, a third of the isolates were PCV13 VT, a lower
proportion than that observed in a pre-PCV study conducted in
rural Gambia where 50% of isolates were PCV13 VT. Serotype 19A,
included in PCV13 but not in PCV7, was one of themost common VT
serotypes, representing approximately 9% of pneumococcal car-
riage. By comparison, in the United States, serotype 19A signiﬁ-
cantly decreased after PCV13 introduction, although it still
contributed up to 5% of the total S. pneumoniae carriage 5 years later
[34]. In South Africa, prevalence of serotype 19A in children was
2.7% two years after the introduction of PCV13 [35].
The prevalence of PCV13 VT among mothers in our study was
8.8% and among newborns was 11.8%. These estimates are consis-
tent with the predictions of a mathematical model of carriage in
The Gambia, which predicted that PCV13 VT carriage would decline
to 7% three years after PCV13 [36]. Although it appears that VT have
decreased, Gambian newborn babies are still unprotected against
VT during a period when they are at high risk of infection, since the
ﬁrst dose in the Expanded Program on Immunization (EPI)
schedule is given at 8 weeks of age in the national EPI.
Between 6% and 10% of isolates were not typeable, similar to
earlier studies conducted after PCV [18,37], but different from
the prevaccine estimates in The Gambia, which were about 2%
[38]. An increase in nontypeable isolates after PCV has been
related to serotypeable isolates that do not express their capsule
[18].Please cite this article in press as: Usuf E, et al., Maternal pneumococcal na
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close to 50%. In Malawi, a lower concordance (9.1%) between
mothers and their newborns was reported, but these infants
were older (<3 months of age) and therefore more likely to ac-
quire carriage from sources other than the mother [39]. The high
concordance appears to be at odds with the low proportion of
neonatal carriage attributable to maternal carriage (population-
attributable fraction), observed both in our study (10.6%) and in
a previous study in rural Gambia (9.5%) [33]. This discrepancy
may suggest that other children in the household may be
transmitting to both mothers and newborns. Compared to the
proportion of neonatal carriage attributable to maternal carriage,
the proportion attributable to living with other children was
considerably higher (62.6%). This was both because the OR was
higher and because carriage was more common in children than
in mothers.
Although the association between other children living in the
household and neonatal carriagewas strong and has been observed
in Asia and other parts of Africa [35,40e42], we cannot exclude the
notion that it is due to differences in socioeconomic status between
households with a small and large number of children.
Other factors associated with neonatal carriage were low birth
weight and dry season. The decreased carriage risk with low birth
weight was a surprising ﬁnding, though it has been reported in
Indian and Dutch babies (https://repub.eur.nl/pub/22193/) [19]
and may be due to behavioural factors, as these children are
perhaps less exposed to other family members. The association
with season was previously shown among older children in rural
Gambia, and we therefore would expect the same pattern with
neonates. Such an association may reﬂect greater social mixing
during the dry season, when villagers spend less time on their
farms [43].
Our analysis has a number of limitations. Firstly, the rates of
carriage may have been underestimated because the women and
their newborns received relatively more medical attention than the
general local population during the study period. In addition, only
healthy mothers and newborns were recruited into the study.
Secondly, the analysis was restricted to motherenewborn pairs
with both swabbed at day 28. Thirdly, the risk factors tested were
not exhaustive. In particular, we did not assess for the presence of
upper respiratory tract infections, which has been shown to in-
crease the risk of carriage [44], and we were unable to explore the
role of breastfeeding because the newborns were all breastfed. The
effect of maternal carriage on newborn carriage may have been
diluted, as about half of the motherenewborns pairs were discor-
dant. Fourthly, we did not use molecular techniques [45], so we
may have missed low-density carriers and cases of multiple
carriage.
Conclusions
Gambian newborns are rapidly colonized by pneumococcus
during the ﬁrst month of life, and current strategies for pneumo-
coccal control in Africa do not protect this age group beyond the
herd effect. More than 2 years after PCV13 introduction (4 years
after PCV7 introduction), PCV13 VT are still transmitted in the
community, representing one-third of strains isolated from
neonatal and maternal nasopharyngeal carriage. Living with other
children was the major risk factor for neonatal carriage.
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